Curbo, Danny .

HRN: 25-94-37  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/24/2024
10/01/2024
IV
4.5g
Q8h
Pneumonia
Waiting Final Action 
09/24/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/24/2024
10/01/2024
IV
600mg
Q8h
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: